Angina Drug No Help for Blocked Vessels Post-PCI

ACC Conference Reporter

TCT 2015 | SAN FRANCISCO — Routine use of the anti-anginal drug ranolazine (Ranexa) for patients with blocked vessels remaining after percutaneous coronary intervention (PCI) didn't reduce subsequent revascularization attempts or hospitalization, the RIVER-PCI trial showed. Read More >>>

Keywords: Transcatheter Cardiovascular Therapeutics

< Back to Listings